Lancashire and South Cumbria
Formulary
Formulary
1 Gastro-intestinal system
01-05-02 Oral
| Budesonide orodispersible tablets (Jorveza) |
|
Formulary
|
Orodispersible tablets 1mg |
 LSCMMG: Budesonide orodispersible tablet NICE TA708: Budesonide orodispersible tablet for inducing remission of eosinophilic oesophagitis |
|
Links
- LSCMMG: Budesonide multimatrix (MMX)
- LSCMMG: Budesonide orodispersible tablet
LSCMMG: Gastroenterology Biologics Pathway- LSCMMG: Primary Care Constipation Guidelines
- MHRA: Corticosteroids: rare risk of central serous chorioretinopathy with local as well as systemic administration
- NICE CG147: Diverticular disease: diagnosis and management
- NICE CG184 Gastro-oesophageal reflux disease and dyspepsia in adults: investigation and management
- NICE CG61: Irritable bowel syndrome in adults: diagnosis and management
- NICE CG61: Irritable bowel syndrome in adults: diagnosis and management of irritable bowel syndrome in primary care
- NICE NG1: Gastro-oesophageal reflux disease: recognition, diagnosis and management in children and young people
- NICE NG147: Diverticular disease: diagnosis and management
- NICE TA708: Budesonide orodispersible tablet for inducing remission of eosinophilic oesophagitis
- NICE TA937: Targeted-release budesonide for treating primary IgA nephropathy
- SPS: Mesalazine monitoring